Pharmaceutical Packaging

Global Pharmaceutical Packaging Market to Reach US$232.7 Billion by 2030

The global market for Pharmaceutical Packaging estimated at US$144.9 Billion in the year 2024, is expected to reach US$232.7 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Plastics & Polymers, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$114.0 Billion by the end of the analysis period. Growth in the Paper & Paperboards segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$48.1 Billion While China is Forecast to Grow at 9.8% CAGR

The Pharmaceutical Packaging market in the U.S. is estimated at US$48.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$35.5 Billion by the year 2030 trailing a CAGR of 9.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

Global Pharmaceutical Packaging Market - Key Trends and Drivers Summarized

Pharmaceutical packaging or drug packaging refers to the packaging solutions as well as the packaging processes related to various pharmaceutical preparations. As an integral part of the pharmaceutical industry, pharmaceutical packaging is a highly regulated industry, with differences existing based on country of origin or region. Types of pharmaceutical packaging vary widely, encompassing blister packs, bottles, vials, ampules, and syringes, among others. Each type is tailored to different requirements based on the chemical and physical properties of the medication, regulatory compliance, and patient convenience. Innovations in materials and design have led to features such as tamper-evidence, child resistance, and mechanisms for improving patient compliance with dosage schedules.

Recent advancements in pharmaceutical packaging focus on enhancing patient safety and compliance, increasing the use of sustainable materials, and incorporating advanced technologies. Smart packaging, equipped with electronic features such as QR codes, RFID tags, and sensors, is gaining traction. These technologies help in monitoring environmental conditions during shipping, verifying authenticity, tracking usage, and providing vital information directly to patients and healthcare providers. Furthermore, there is a strong trend towards sustainability in pharmaceutical packaging, with an increasing number of companies investing in biodegradable and recyclable materials to reduce environmental impact. This shift is supported by stringent regulations and growing consumer awareness about environmental issues. Labeling & serialization is anticipated to grow at a significant pace, owing to enforcement of stringent environmental and labeling regulations, and a growing need for product traceability, arising from rising overseas shipments and Internet-based procurement.

The growth in the pharmaceutical packaging market is driven by several factors including stringent regulatory requirements for the safety and quality of pharmaceutical products, which mandate the use of advanced packaging solutions. The advent of novel biochemical compounds and drug delivery systems along with innovations in pharmaceuticals like blow fill seal vials, prefilled syringes and powder applications are influencing the packaging market. The global market is bolstered by growth of the generic and OTC drugs market, advent of integrated, flexible and automated packaging equipment, and enforcement of stringent packaging regulations to discourage counterfeit products. Another factor driving the market growth is rising geriatric population and increasing incident of chronic conditions, The increasing global pharmaceutical production and the expansion of the healthcare sector, particularly in emerging markets, also significantly contribute to market expansion. Technological innovations, such as the development of anti-counterfeit measures and condition-sensitive packaging, are vital in addressing the concerns about drug safety and efficacy. Additionally, the rising prevalence of chronic diseases has led to an increase in the demand for pharmaceuticals that require specialized packaging solutions to ensure stability and dosing accuracy.

SCOPE OF STUDY:

The report analyzes the Pharmaceutical Packaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Material (Plastics & Polymers, Paper & Paperboards, Glass, Metals, Other Materials); Product Type (Plastic Bottles, Parenteral Containers, Caps & Closures, Blister Packs, Labels & Accessories, Pre-Fillable Syringes, Pre-Fillable Inhalers, Other Product Types); End-Use (Pharmaceutical Manufacturing, Contract Packaging, Retail Pharmacy, Institutional Pharmacy, Other End-Uses)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 246 Featured) -

• Bemis Co., Inc.
• Ball Corporation
• Applied DNA Sciences, Inc.
• Bilcare Ltd.
• Agrado SA
• Bisio Progetti S.P.A.
• Beatson Clark PLC
• ACG Pharmapack Pvt., Ltd.
• Acme Vials and Glass Company, LLC
• Arab Pharmaceutical Glass Co.
• Action Packaging & Design, Inc.
• Assemblies Unlimited, Inc.
• Abhishek Glass International Pvt. Ltd.
• BeyonDevices
• As One Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.